FRAZIER KENNETH C bought EIKN
March 2, 2026 · Form 4 insider transaction
FRAZIER KENNETH C bought 25,873 shares of Eikon Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,873
Price
$0.00
Total value
N/A
InsiderFRAZIER KENNETH C
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 2, 2026
Filing dateMarch 4, 2026
Shares owned after25,873
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/48th of the shares underlying the option will vest on each monthly anniversary of the vesting start date for 48 months, subject to the Reporting Person's continued service through each date.